Jump to content

Paxlovid and Molnupiravir COVID-19 treatments planned to be purchased


webfact

Recommended Posts

S__76685323.jpg

 

Thailand’s Ministry of Public Health is to seek cabinet approval this week for the procurement of two anti-viral drugs, Pfizer’s Paxlovid and Merck’s Molnupiravir, for the treatment of people in early infection with COVID-19.

 

Dr. Attasit Srisubat, an advisor to the Department of Medical Services, said that he expects the two oral treatments to be available in Thailand in December or January, after the completion of the Thai Food and Drug Administration registration process.

 

He also said that Thai health officials are due to meet with representatives of Pfizer’s Thailand representatives this Friday to discuss details of the procurement, as he stressed the government’s intention to procure effective anti-rival drugs to treat COVID-19 as soon as possible, as early access to them will help in the containment of the pandemic.

 

Discover Cigna’s range of health insurance solutions created for expats and local nationals living in Thailand - click to view

 

Full story: https://www.thaipbsworld.com/paxlovid-and-molnupiravir-covid-19-treatments-planned-to-be-purchased/

 

Logo-top-.png
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.










×
×
  • Create New...